A synthesized gamma distribution‐based patient‐specific VMAT QA using a generative adversarial network
Medical Physics · 2023
DOI: 10.1002/mp.16210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Physics, 2023. Verfasst von Takaaki Matsuura und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan. Hauptthemen laut MEDLINE: Radiotherapy, Intensity-Modulated, Prostatic Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
Background
Artificial intelligence (AI)‐based gamma passing rate (GPR) prediction has been proposed as a time‐efficient virtual patient‐specific QA method for the delivery of volumetric modulation arc therapy (VMAT). However, there is a limitation that the GPR value loses the locational information of dose accuracy.
Purpose
The objective was to predict the failing points in the gamma distribution and the GPR using a synthesized gamma distribution of VMAT QA with a deep convolutional generative adversarial network (GAN).
Methods
The fluence maps of 270 VMAT beams for prostate cancer were measured using an electronic portal imaging device and analyzed using gamma evaluation with 3%/2‐mm, 2%/1‐mm, 1%/1‐mm, and 1%/0.5‐mm tolerances. The 270 gamma distributions were divided into two datasets: 240 training datasets for creating a model and 30 test datasets for evaluation. The image prediction network for the fluence maps calculated by the treatment planning system (TPS) to the gamma distributions was created using a GAN. The sensitivity, specificity, and accuracy of detecting failing points were evaluated using measured and synthesized gamma distributions. In addition, the difference between measured GPR ( m GPR) and predicted GPR ( p GPR) values calculated from the synthesized gamma distributions was evaluated.
Results
The root mean squared errors between m GPR and p GPR were 1.0%, 2.1%, 3.5%, and 3.6% for the 3%/2‐mm, 2%/1‐mm, 1%/1‐mm, and 1%/0.5‐mm tolerances, respectively. The accuracies for detecting failing points were 98.9%, 96.9%, 94.7%, and 93.7% for 3%/2‐mm, 2%/1‐mm, 1%/1‐mm, and 1%/0.5‐mm tolerances, respectively. The sensitivity and specificity were the highest for 1%/0.5‐mm and 3%/2‐mm tolerances, which were 82.7% and 99.6%, respectively.
Conclusions
We developed a novel system using a GAN to generate a synthesized gamma distribution‐based patient‐specific VMAT QA. The system is promising from the point of view of quality assurance in radiotherapy because it shows high performance and can detect failing points.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan.
- Department of Radiation Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
- Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima, Japan.
Zitieren
APA
Matsuura, T., Kawahara, D., Saito, A., Yamada, K., Ozawa, S., & Nagata, Y. (2023). A synthesized gamma distribution‐based patient‐specific VMAT QA using a generative adversarial network. Medical Physics. https://doi.org/10.1002/mp.16210
Vancouver
Matsuura T, Kawahara D, Saito A, Yamada K, Ozawa S, Nagata Y. A synthesized gamma distribution‐based patient‐specific VMAT QA using a generative adversarial network. Medical Physics. 2023. doi:10.1002/mp.16210
BibTeX
@article{Matsuura2023,
author = {Matsuura, Takaaki and Kawahara, Daisuke and Saito, Akito and Yamada, Kiyoshi and Ozawa, Shuichi and Nagata, Yasushi},
title = {A synthesized gamma distribution‐based patient‐specific VMAT QA using a generative adversarial network},
journal = {Medical Physics},
year = {2023},
doi = {10.1002/mp.16210}
}
EUVIMED